The global AI in healthcare market is anticipated to grow at a CAGR of around 51.5% during the forecast period (2021-2027). The key factor to drive the market growth is the increased use of robotic-assisted surgeries where cognitive robotics can integrate information from pre-operation medical records along with real-time operating metrics to physically improve the accuracy of the physician's instrument.

Global cloud computing market is anticipated to grow at a substantial CAGR of 15.6% during the forecast period (2024-2031). Cloud computing refers to storing, processing, and handling data on a remote computer’s network hosted on the internet instead of a local server or personal computer. The major driving factors influencing the market growth are increasing digital transformation across businesses, growing internet and mobile device adoption across the globe, and increased usage of big data. The rising number of large enterprises across developed and emerging nations will surge the demand for cloud computing services over the forecast period.

The global industrial air compressor market is anticipated to grow at a considerable CAGR of 4.3% during the forecast period (2022-2028).  The global industrial air compressor market is driven by its application among various end-user industries and the advanced features and technology offered by an industrial air compressor. 

The global packaging machinery market is anticipated to grow at a considerable CAGR of 4.7% during the forecast period.(2022-2028). The contribution of major key market players, enhances the growth of the global packaging machinery market in the coming year. Standard-Knapp(S-K), based in Portland, unveiled its deal with EoL Packaging Experts(EoL)- In September 2019, Standard-Knapp(S-K) Connecticut, announced an agreement to partner with Eol packaging experts (EoL). The merger creates an active industry leader for end-of-line packaging machinery and systems with a presence in the US and Europe. The EoL portfolio includes A+F Automation+  Fördertechnik (A+F), and secondary packaging equipment. With A+F and Standard-Knapp packaging equipment, the company was continuously working to expand their technological advantages. 

Advances in prostate cancer have been witnessed across the countries, such as the US, Canada, China, and Germany. In the US, National Cancer Institute (NCI) offers funding to the researchers to advance the understanding regarding prevention, detection, and treatment of prostate cancer.

The European solar panel market is estimated to grow at a significant CAGR of 11% during the forecast period. The key companies across the globe are highly inclined toward the adoption of different growth strategies including capacity expansion, mergers and acquisitions, new product launches, and product innovation to remain competitive in the marketplace.

Indian dicalcium phosphate (feed grade) market to grow at a CAGR of more than 6% during the forecast period. A significant rise in animal feed industry has witnessed in India owing to the rising cattle and poultry population and considerable exports of dairy products.

The global male infertility diagnosis and treatment market is estimated to grow at a CAGR of more than 4% during the forecast period. Due to the rising incidences of male infertility, there are various developments taking place to provide an effective and reliable solution to overcome this problem. For instance, in May 2019, Aytu BioScience, Inc. declared the availability of MiOXSYS in UK.

The global construction chemicals market is anticipated to grow at a considerable CAGR of 7.8% during the forecast period.  Concrete admixtures are additives to the concrete mix that are added before or during the mixing process. Concrete admixtures lower the cost of concrete construction by altering the properties of hardened concrete, resulting in higher quality during mixing, transport, placement, and curing. This enables users to deal with unexpected situations during concrete operations. 

The global In-Vitro Diagnostics (IVD) market is estimated to grow at a CAGR of 6.2% during the forecast period. Several partnerships among biopharmaceutical companies have led the development of IVD technology.